A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Retatrutide mimics the effects of naturally occurring gut hormones to improve metabolic health. Stimulating insulin release ...

Compounders had been allowed to produce and sell hundreds of thousands of their own versions of popular anti-obesity drugs, ...

Since 1960, the number of U.S. adults who are obese has tripled, and severe obesity has increased by 10 times. Obesity is one ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

Eli Lilly & Co. said Tuesday it’s cutting the ... a regulatory ruling that there’s no longer a shortage of weight-loss drugs that had allowed for alternatives to be made, sending the stock ...

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight ... new once-daily pill for weight loss called orforglipron, at a time when GLP-1 drugs from Lilly and its competitor ...

Lilly is launching two new doses and cutting prices for self-paying customers Eli Lilly & Co. said Tuesday ... there's no longer a shortage of weight-loss drugs that had allowed for alternatives ...

(CNN) — Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the United ...

(CNN) — Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the ...